Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Molecular Programs of Glomerular Hyperfiltration in Early Diabetic Kidney Disease

Vidar T. N. Stefansson, Viji Nair, Toralf Melsom, Helen C. Looker, Laura H. Mariani, Damian Fermin, Felix Eichinger, Rajasree Menon, Lalita Subramanian, Jennifer L. Harder, Jeffrey B. Hodgin, Peter J. Nelson, Bjørn O. Eriksen, Robert G. Nelson, Matthias Kretzler
doi: https://doi.org/10.1101/2021.09.13.21263340
Vidar T. N. Stefansson
1Metabolic and Renal Research Group, UiT The Arctic University of Norway, Tromsø, Norway
2University Hospital of North Norway, Tromsø, Norway
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viji Nair
3University of Michigan, Department of Internal Medicine, Ann Arbor, MI, USA
4Medical Clinic and Policlinic IV, Nephrology Center, University of Munich, Germany
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toralf Melsom
1Metabolic and Renal Research Group, UiT The Arctic University of Norway, Tromsø, Norway
2University Hospital of North Norway, Tromsø, Norway
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen C. Looker
5Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA
MBBS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura H. Mariani
3University of Michigan, Department of Internal Medicine, Ann Arbor, MI, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Damian Fermin
3University of Michigan, Department of Internal Medicine, Ann Arbor, MI, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix Eichinger
3University of Michigan, Department of Internal Medicine, Ann Arbor, MI, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajasree Menon
3University of Michigan, Department of Internal Medicine, Ann Arbor, MI, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lalita Subramanian
3University of Michigan, Department of Internal Medicine, Ann Arbor, MI, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer L. Harder
3University of Michigan, Department of Internal Medicine, Ann Arbor, MI, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey B. Hodgin
3University of Michigan, Department of Internal Medicine, Ann Arbor, MI, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter J. Nelson
4Medical Clinic and Policlinic IV, Nephrology Center, University of Munich, Germany
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bjørn O. Eriksen
1Metabolic and Renal Research Group, UiT The Arctic University of Norway, Tromsø, Norway
2University Hospital of North Norway, Tromsø, Norway
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert G. Nelson
5Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Kretzler
3University of Michigan, Department of Internal Medicine, Ann Arbor, MI, USA
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kretzler@umich.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Hyperfiltration (HF) is a state of high glomerular filtration rate (GFR) observed in early diabetes that damages glomeruli, resulting in an iterative process of increasing filtration load on fewer and fewer remaining functional glomeruli. To delineate underlying cellular mechanisms of damage induced by HF, transcriptional profiles of kidney biopsies from Pima Indians with type 2 diabetes with or without early-stage diabetic kidney disease (DKD) were grouped into two HF categories based on annual iothalamate GFR measurements. Twenty-six participants with a peak GFR measurement within two years of biopsy were categorized as the “HF group”, and 26 in whom biopsy preceded peak GFR by >2 years were considered “pre-HF”. The HF group had higher hemoglobin A1c, higher urine albumin-to-creatinine ratio, increased glomerular basement membrane width and lower podocyte density compared to the pre-HF group. A glomerular 1240-gene transcriptional signature identified in the HF group was enriched for endothelial stress response signaling genes, including from endothelin-1, tec-kinase and TGF-β1 pathways, with the majority of the transcripts mapped to endothelial and inflammatory cell clusters in kidney single cell transcriptional data. This analysis reveals molecular pathomechanisms contributing to development of HF and early DKD and involving putative ligand-receptor pairs and downstream intracellular targets linked to cellular crosstalk between endothelial and mesangial cells.

Competing Interest Statement

Dr. Kretzler reports grants from NIH, non-financial support from University of Michigan, during the conduct of the study; grants from JDRF, Astra-Zeneca, NovoNordisc, Eli Lilly, Gilead, Goldfinch Bio, Merck, Chan Zuckerberg Initiative, Janssen, Boehringer-Ingelheim, Moderna, Chinook, amfAR, Angion, RenalytixAI, Retrophin, European Union Innovative Medicine Initiative and Certa outside the submitted work; In addition, Dr. Kretzler has a patent PCT/EP2014/073413, Biomarkers and methods for progression prediction for chronic kidney disease licensed. Dr. L. H. Mariani has received unrelated research funding from NIH-NIDDK, NephCure Kidney International, NCATS, unrelated consulting fees from Reata Pharmaceuticals, Calliditas Therapeutics, Travere Therapeutics, support from Reata Pharmaceuticals for travel to meetings. Dr. J.B. Hodgin reports unrelated grant funding from NIDDK and was Chair of the Renal Pathology Society Research Committee from 2019-2020.

Funding Statement

This work was supported in part by the Intramural Research Program at the National Institute of Diabetes and Digestive and Kidney Diseases (DK069062) to HCL and RGN, the American Diabetes Association (Clinical Science Award 1-08-CR-42) to RGN, and (DK083912, DK082841, DK020572, DK092926) to RGK, by the extramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases R24 DK082841 Integrated Systems Biology Approach to Diabetic Microvascular Complications and P30 DK081943 University of Michigan O'Brien Kidney Translational Core Center to MK, via the Chan Zuckerberg Initiative Human Cell Atlas Kidney Seed Network to MK and by JDRF 5-COE-2019-861-S-B JDRF and M-Diabetes Center of Excellence at the University of Michigan to MK.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Each participant signed an informed consent document, and the study was approved by the Institutional Review Board of the National Institute of Diabetes and Digestive and Kidney Diseases.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Due to ethical considerations including individual privacy protection concerns, the board stipulated that individual-level genotype and gene expression data from this study cannot be made publicly available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 16, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Programs of Glomerular Hyperfiltration in Early Diabetic Kidney Disease
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Molecular Programs of Glomerular Hyperfiltration in Early Diabetic Kidney Disease
Vidar T. N. Stefansson, Viji Nair, Toralf Melsom, Helen C. Looker, Laura H. Mariani, Damian Fermin, Felix Eichinger, Rajasree Menon, Lalita Subramanian, Jennifer L. Harder, Jeffrey B. Hodgin, Peter J. Nelson, Bjørn O. Eriksen, Robert G. Nelson, Matthias Kretzler
medRxiv 2021.09.13.21263340; doi: https://doi.org/10.1101/2021.09.13.21263340
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Molecular Programs of Glomerular Hyperfiltration in Early Diabetic Kidney Disease
Vidar T. N. Stefansson, Viji Nair, Toralf Melsom, Helen C. Looker, Laura H. Mariani, Damian Fermin, Felix Eichinger, Rajasree Menon, Lalita Subramanian, Jennifer L. Harder, Jeffrey B. Hodgin, Peter J. Nelson, Bjørn O. Eriksen, Robert G. Nelson, Matthias Kretzler
medRxiv 2021.09.13.21263340; doi: https://doi.org/10.1101/2021.09.13.21263340

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Nephrology
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (553)
  • Anesthesia (135)
  • Cardiovascular Medicine (1761)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (660)
  • Epidemiology (10803)
  • Forensic Medicine (8)
  • Gastroenterology (593)
  • Genetic and Genomic Medicine (2953)
  • Geriatric Medicine (287)
  • Health Economics (534)
  • Health Informatics (1930)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (631)
  • Infectious Diseases (except HIV/AIDS) (12520)
  • Intensive Care and Critical Care Medicine (693)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2801)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1469)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (867)
  • Pharmacology and Therapeutics (366)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2641)
  • Public and Global Health (5374)
  • Radiology and Imaging (1014)
  • Rehabilitation Medicine and Physical Therapy (596)
  • Respiratory Medicine (726)
  • Rheumatology (330)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (126)